Die folgenden Informationen sind nur auf Englisch verfügbar:
EIT Health and the European investment Fund (EIF) are partnering to operate the Venture Centre of Excellence (VCOE), a public-private co-investment programme to empower finance for European health small and medium size enterprises (SMEs).
The VCOE connects life science investors with high investment capacities such as venture capital funding, corporate or industrial firms, Technology Transfer Offices, insurers and more – with highly qualified Pan-European SMEs using an exclusive artificial intelligence platform that brings all members together.
Companies in the programme receive support to fundraise and have key access to services provided by EIT Health in support of their Series A, B and up to pre-IPO fundraising rounds.
Become part of the programme that already encompasses 1.7 € billion of investment capabilities!
HealthTech Innovation Days (HTID)
For the first time, VCOE investor members gathered in Paris in person and virtually during HTID. During VCOE the exclusive sessions, they interacted with each other, and the first assessed companies were there to shape collaboratively and pursue co-investments.
4-5 October 2021 – Paris, France
Sachs HealthTech Investment Forum
EIT Health is the sponsoring partner of the Sachs HTIF. Kurt Höller, EIT Health Director of Business Creation, moderated and organised the HTIP joint pitch session.
5-6 October 2021 – Virtual
To qualify, your SME must:
Fees to complete the assessment process for companies are €2,000.
Companies that are successful in the selection process and wish to confirm their participation in the VCOE will pay a service and mentorship fee of €8,000.
Upon successful fundraising within the VCOE programme, the SME will pay a percentage-calculated fee of the capital that has been raised thanks to new investors in the company. Further details will be provided during the application process.